AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India

Objective: To determine the therapeutic efficacy and safety of AYUSH-64 as an add-on to standard care in mild to moderate COVID-19. Design setting, and interventions: This open-label randomized controlled parallel-group trial was conducted at a designated COVID care centre in India in 80 patients di...

Full description

Bibliographic Details
Main Authors: Harbans Singh, Sumit Srivastava, Babita Yadav, Amit K. Rai, Sophia Jameela, Sanuj Muralidharan, Rijin Mohan, Shikha Chaudhary, Richa Singhal, Rakesh Rana, Shruti Khanduri, Bhagwan S. Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Sarika Chaturvedi
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Complementary Therapies in Medicine
Subjects:
Ayurveda
COVID-19
Integrative medicine
Pandemic
Viral disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0965229922000164

Internet

http://www.sciencedirect.com/science/article/pii/S0965229922000164

Similar Items